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Abstract
ICln, a cytosolic protein associated with a nucleotide-sensitive chloride current, may be involved in the regulation of a
volume-regulated anion current (VRAC) associated with hypotonic cell swelling. We have determined the nucleic acid
sequences of ICln from human tsA201a, colonic (T84) and myeloma (RPMI 8826) cell lines. The amino acid sequences are
highly homologous (v 99%) to each other but less homologous to ICln protein from other species. Using the whole-cell patch
clamp technique, we examined the effect of ICln protein expression levels on VRAC properties during a hyposmotic challenge.
Overexpression of T84 or RPMI 8226-derived ICln protein in tsA201a cells results in a more than 9-fold increase in the rate of
VRAC activation over control values, while having no effect on VRAC inactivation properties. Underexpression of
endogenous ICln protein in tsA201a cells using antisense oligonucleotides results in a more than 180-fold decrease in VRAC
activation rate as compared to control values. These results indicate that ICln protein expression modulates VRAC activation
but not inactivation. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: ICln ; Volume-regulated anion current (VRAC); Cell volume regulation; Regulatory volume decrease
1. Introduction
Activation of a volume-regulated anion current
(VRAC) during hypotonic swelling occurs in many
cell types, although the regulation of VRAC is
poorly understood. One protein thought to be asso-
ciated with regulation of cell swelling is ICln (protein
associated with a nucleotide-sensitive chloride cur-
rent). ICln protein is a small, 27 kDa, ubiquitously
expressed cytosolic protein whose function in volume
regulation remains controversial. Originally cloned in
MDCK cells, ICln was initially thought to be a
VRAC based on protein expression in Xenopus oo-
cytes [1], although this is no longer the case (see [19]
for review).
Studies suggest ICln protein expression levels may
contribute to volume regulatory processes by modu-
lating a volume regulated anion current [2,3]. Under-
expression of ICln protein using antisense oligonu-
cleotides inhibits VRAC activation in bovine
nonpigmented ciliary epithelial cells and ¢broblasts
while ICln protein overexpression increases VRAC
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activation rate during cell swelling [3,4]. Other recent
studies suggest ICln modulation of VRAC may occur
indirectly, through the regulation of cellular pro-
cesses such as transcription, translation, second mes-
senger cascades and cytoskeletal rearrangement [5].
Alternatively, Li et al. report that ICln protein inser-
tion in lipid bilayers results in a cation-selective cur-
rent [6].
The data reported here support the hypothesis that
ICln protein expression level modulates the activation
of VRAC, although the properties of voltage-depen-
dent inactivation are not a¡ected. We have deter-
mined the amino acid sequences of ICln from human
tsA201a (epithelial), T84 (colon) and RPMI 8226
(myeloma) cells, which are v 99% homologous to
other human sequences and display 90% and 92%
homology to rat and MDCK ICln, respectively. ICln
protein expression levels (of either T84 or RPMI
origin) modulate VRAC activation in response to
cell swelling in tsA201a cells. Overexpression of
T84 or RPMI 8226-derived ICln protein increased
the rate of VRAC activation and current amplitude
in tsA201a cells, while underexpression of endoge-
nous ICln protein in tsA201a cells inhibited the rate
of VRAC activation. VRAC inactivation properties
are independent of both protein expression and pro-
tein sequence. There was no indication that an in-
crease in ICln protein expression resulted in the ex-
pression of a cation current. Some of the work
presented here has been previously presented in ab-
stract form [7^9].
2. Materials and methods
2.1. Cell lines and tissue culture
tsA201a cells were grown in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% fetal bovine
sera (FBS, Gibco BRL), myeloma (RPMI 8226) were
grown in suspension with RPMI 1640 supplemented
with L-glutamine (300 mg/l) and 20% FBS (Cell
Grow of Fisher Scienti¢c/Mediatech, Washington,
DC, USA) and T84 epithelial cells were grown in
DMEM/F12 (Gibco BRL) and 5% FBS. All media
contained penicillin (100 U/ml) and streptomycin
(100 Wg/ml) (Gibco BRL) and cells were fed and/or
split every 2^3 days.
2.2. Isolation of ICln cDNA
Total RNA was isolated using a MicroRNA iso-
lation kit from Stratagene (La Jolla, CA, USA) and
treated with RNase-free Dnase (RQ1, Promega,
Madison, WI, USA) for 30 min at 37‡C to remove
any genomic DNA contaminants. Reverse tran-
scription (RT) was conducted using random hexa-
nucleotide primers. ICln cDNA was ampli¢ed by
PCR (GeneAmp RNA PCR kit, Perkin Elmer,
Branchburg, NJ, USA) using primers complemen-
tary to the 5P and 3P regions of the MDCK ICln
sequence: upstream primer: 5P-CCG GAT CCA
TGA GCT TCC TCA AAA GT-3P, downstream
primer: 5P-CCG AAT TCG TGA TCA ACA TCT
GCA TC-3P.
First strand cDNA was synthesized using 1 Wg
total RNA and MuLV reverse transcriptase (Perkin
Elmer, Branchburg, NJ, USA) in a 100 Wl PCR
reaction consisting of: 10 mM Tris^HCl (pH 8.3),
50 mM KCl, 2 mM MgCl2 and 15 pmol of each
primer. Ampli¢cation was carried out using the fol-
lowing protocol: 1 cycle at 95‡C for 5 min; 35 cycles
at 94‡C for 1 min, 64‡C for 1 min and 72‡C
for 4 min; 1 cycle at 72‡C for 10 min. The RT-
PCR product was run on a 1.0% agarose gel
and visualized using ethidium bromide (10 mg/ml).
A band of the expected size (715^730 bp) was ob-
served.
The PCR product was ligated into the 5 kb pCR
3.1-Uni or -Bi vector (Invitrogen, Carlsbad, CA,
USA) in a 10 Wl reaction containing: 120 ng ICln
PCR product, 60 ng pCR 3.1 vector, 1 Wl of T4
DNA ligase, 1 Wl of 10U ligation bu¡er and sterile
water and incubated overnight at 14‡C. The pCR 3.1
vector was subsequently transformed into TOP 10FP
One Shot cells (Invitrogen, Carlsbad, CA, USA) in a
reaction consisting of: 2 Wl L-mercaptoethanol, 20 ng
ligation reaction product and 50 Wl One Shot cells
and incubated on ice for 30 min. Cells were heat-
shocked for 30 s (42‡C), cooled on ice, added to
SOC (450 ml) media and placed in a shaking incu-
bator for 1 h (37‡C). The solution (50^200 Wl) was
spread onto LB agar plates pre-treated with ampicil-
lin (50 Wg/ml) and colonies were grown overnight in a
37‡C incubator. Five to ten colonies were selected,
added to TYP media and placed in a shaking incu-
bator (37‡C) for 14^16 h. Small quantities of the
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pCR 3.1 vector (containing ICln cDNA insert) were
isolated from successfully transformed bacterial cells
using Wizard Plus Miniprep kit (Promega) and re-
stricted with EcoRI, run on a 1.0% agarose gel and
visualized using ethidium bromide (10 mg/ml). Re-
striction enzyme digestion resulted in the expected
5 kb (pCR 3.1 vector) and 715^730 bp (ICln cDNA)
products. Once successfully transformed bacterial
colonies were identi¢ed, large quantities of ICln
cDNA were isolated using the Maxi-prep kit
(5 PrimeC3 Prime, Boulder, CO, USA).
2.3. DNA sequencing
ICln cDNA from tsA201a, T84 and RPMI 8226
cells was ligated in the pCR 3.1-Uni or -Bi vector
as described previously and sequenced using Seque-
nase Version 2.0 DNA Sequencing Kit (USB, Cleve-
land, OH), based on the chain-terminating dideoxy-
nucleotide method developed by Sanger et al. [10].
Synthesis is initiated by a primer designed to anneal
to the M13 region of the pCR 3.1 vector and termi-
nation occurs when a 2P, 3P-dideoxynucleoside 5P-tri-
phosphate lacking the 3P-OH is randomly incorpo-
rated into the growing nucleotide chain. A set of
nested primers was designed to amplify the region
between 300^500 bp. The nested primer sequences
were as follows: upstream nested primer: 5P-GAT
GGC TCT GGA TTA GGA TTCT-3P, downstream
nested primer: 5P-TGT CCC CCT GTC CTT GTT
CA-3P. [K-35S]dATP is included in the reaction in
order to visualize the products via autoradiography
following polyacrylamide gel electrophoresis. Be-
cause of the extremely high homology of the human
sequences, ICln cDNA from each cell type was
sequenced more than once, either in our labora-
tory and/or at two di¡erent commercial sequenc-
ing facilities. Sequencing results from all sources
agreed.
2.4. ICln over- and underexpression
tsA201a cells were split and transfected 24 h later
with either RPMI 8226 or T84-derived ICln cDNA
using the calcium-phosphate method [11]. Cells
were co-transfected with either GFP or CD8 to iden-
tify successful transfectants [12]. GFP, isolated from
the jelly¢sh Aequorea victoria, is a 27 kDa cytosolic
protein which £uoresces when excited with UV light.
CD8 is a 32 kDa cell-surface glycoprotein involved in
antigen recognition in human T cells. CD8 co-trans-
fected cells were identi¢ed using polystyrene beads
coated with a primary monoclonal antibody speci¢c
for the CD8 antigen.
Underexpression of endogenous ICln protein was
accomplished by transfecting tsA201a cells with a
set of previously published antisense oligonucleotides
using Lipofectin Reagent (Gibco BRL, Grand Is-
land, NY, USA) [3]. The 31-mer is complementary
to the ¢rst 31 nucleotides of the MDCK ICln se-
quence. A set of sense oligonucleotides consisting
of the ¢rst 24 nucleotides of MDCK ICln was used
as a control in the underexpression studies. Each
base in both nucleotide sequences was phosphoro-
thioated to deter degradation by intracellular nucle-
ases. The sequences are as follows: antisense 5P-CGG
CGG CGG GAA ACT TTT TGA GGA AGC TCA
T-3P, sense 5P-ATG AGC TTC CTC AAA AGT
TTC CCG-3P.
Lipofectin Reagent (Gibco BRL) is a liposome
complex composed of the cationic lipid N-[1-(2,3-di-
oleyloxy)propyl]-n,n,n-trimethylammonium chloride
(DOTMA) and dioleoly-phosphatidylethanolamine
(DOPE) in a 1:1 ratio. A solution containing 1^2
Wg cDNA, 200 Wl serum-free DMEM and 10 Wl Lip-
ofectin Reagent was incubated for 45 min at room
temperature. 0.8 ml of serum-free DMEM was added
to the cDNA^liposome complex and this mixture
was overlaid onto tsA201a cells and incubated for
7^10 h in a 5% CO2 incubator maintained at 37‡C.
Mock-transfected cells were treated identically with
the exception that cDNA was not added to the lipo-
some complex. Following lipofection, cells were re-
suspended in 2 ml of serum-containing DMEM and
split onto cover slips 24 h later.
2.5. Immuno£uorescence
Immuno£uorescence was used to con¢rm under-
and overexpression of ICln protein in transfected
tsA201a cells. Adherent cells were grown (tsA201a,
T84) on cover slips coated with polylysine and ¢xed
in 3.7% formaldehyde in phosphate-bu¡ered saline
(PBS, pH 7.0), washed in PBS three times, 2 min
each, permeabilized with 0.1% Triton in PBS, fol-
lowed by 3% goat sera (Sigma, St. Louis, MO,
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USA) in PBS for 2, 30 and 2 min. RPMI 8226 cells,
which grow in suspension, were allowed to settle
onto coverslips before ¢xation. Cells were incubated
with polyclonal rabbit K-ICln (1:200, 60 min) fol-
lowed by £uorescent (Cy-3)-labeled secondary anti-
body (30 min). All cells were washed in PBS (¢ve
times, 3 min each) and mounted using SlowFade
(Molecular Probes, Lake Owsego, OR, USA) to pre-
vent fading. Staining and ¢xing was performed at
room temperature (22‡C þ 2). Fluorescent images
were taken using phase contrast microscopy with a
Nikon Diaphot microscope. Fluorescence was quan-
ti¢ed by taking images through a center plane of a
cell and determining the mean pixel intensity per cell
using Scion Image 1.57b. Polyclonal K-ICln antibod-
ies were generous gifts from Dr. K. Strange and Dr.
Jan Eggermont.
2.6. Solutions
The standard extracellular solution contains (in
mM): 150 NaCl, 2 MgCl2, 1 CaCl2, 10 HEPES,
pH 7.2. The intracellular solution was composed of
(in mM): 150 Cs-glutamate, 10 HEPES, 0.1 CaCl2,
1.1 EGTA, 4 ATP, pH 7.2 using CsOH. Cs-Gluta-
mate was used in the intracellular solution to block
K currents.
The osmolality of the extracellular and intracellu-
lar solutions was determined prior to every experi-
ment using a vapor pressure osmometer (Wescor,
Logan, UT, USA). VRAC is activated only in the
presence of a hyposmotic gradient. Sucrose was
added to the intracellular solution so that it was
30^40 mOsm greater with respect to the bath solu-
tion. Relative osmolality is de¢ned as: [(extracellular
osmolality/intracellular osmolality)U100]. A hypo-
smotic gradient of 90% was within physiological rel-
evant range.
2.7. Electrophysiological recording and analysis
Macroscopic currents were recorded using the
whole-cell patch clamp technique [13] and analyzed
as previously described [14].
3. Results
3.1. Identi¢cation of ICln cDNA
Total RNA from tsA201a, T84 and RPMI 8226
cells was isolated and converted into cDNA. Primers
(as described in Section 2) designed to anneal to the
published MDCK ICln sequence were used to amplify
a similar sequence from each cell line using polymer-
ase chain reaction (PCR). PCR products were shown
to be between 715^735 bp when visualized on a 1.0%
agarose gel as expected. The ICln PCR product was
ligated into the pCR 3.1-Uni or -Bi vector for DNA
sequence analysis and transient transfections in
tsA201a cells. Fig. 1 compares these sequences, trans-
lated into amino acids, with previously published
human ocular (HuO), rat and MDCK ICln. ICln ami-
no acid sequences from T84, RPMI 8226, tsA201a
and HuO were v 99% homologous with 90% and
92% homologous to rat and MDCK sequences, re-
spectively.
3.2. Overexpression of ICln protein
The e¡ect of ICln protein overexpression on VRAC
properties was examined in tsA201a cells overex-
Fig. 1. tsA201a, T84 and RPMI 8226 ICln amino acid sequences. The C-terminus of amino acid sequences are compared to previously
published human ocular (HuO), rat and MDCK sequences. Changes from the MDCK amino acid sequence are indicated by * and
are bold in the rat sequence. Di¡erences in the HuO sequence are indicated by open boxes whereas di¡erences in amino acids in,
RPMI 8226, T84 and tsA201a cell lines are shown by ¢lled boxes. GenBank accession numbers are tsA201a: AF232708, RPMI 8226:
AF232225 and T84: AF232224.
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pressing ICln protein derived from either T84 or
RPMI 8226 cells. ICln protein over-expression was
con¢rmed by incubating ¢xed transfected tsA201a
cells with polyclonal rabbit K-ICln antibody and visu-
alized using a £uorescent-tagged secondary antibody.
Fig. 2 shows cells with two levels of £uorescence
intensity. tsA201a cells co-transfected with ICln and
marker (GFP or CD8) showed a higher level of £uo-
rescence intensity, indicating an increased level of
ICln protein expression over endogenous expression.
The mean pixel intensity is greater in myeloma-de-
rived ICln transfected tsA201a than in mock trans-
fectants (147 þ 10 and 88 þ 9, respectively). This e¡ect
was the same regardless of the source of ICln. ICln
protein expression in cells transfected with marker
alone were similar to mock transfectants. Note that
overexpression does not alter the homogeneous pat-
tern of ICln protein distribution.
Fig. 2. Overexpression of ICln protein in tsA201a cells. (A) K-ICln followed by incubation with a £uorescent (Cy-3) secondary antibody
demonstrates an increase in ICln protein expression in transfected cells expressing a co-expressed marker (GFP) as compared to mock
transfected cells. Scale bar indicates 10 Wm. (B) Mean pixel intensity ( þ S.E.M.) per cell under each condition. tsA201a cells co-trans-
fected with GFP and T84 derived ICln cDNA. Cells were considered to be co-transfected if both red (Cy-3) and green (GFP) £uores-
cence was detected. Mean pixel intensity was taken from v 25 cells per condition.
Fig. 3. ICln protein overexpression increases VRAC activation rate. (A) VRAC was activated in control and tsA201a cells expressing
T84 ICln protein in response to a 90% hyposmotic gradient. Current was elicited in response to a series of voltage ramps from 360 to
+60 mV over 500 ms, applied every 10 s. Superimposed currents were taken at times 0, 20, 40, 60 and 80 s. (B) The time course of
VRAC current development. The activation rate was 15-fold greater in tsA201a cells transfected with T84 ICln cDNA (open symbols:
79 þ 24 pA/pF min31) as compared to CD8-transfected control cells (¢lled symbols: 5 þ 3 pA/pF min31). Each point represents an
average of recordings made from v 8 cells þ S.E.M.
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3.3. E¡ect of ICln protein overexpression on the rate of
VRAC activation
The e¡ect of ICln protein overexpression on VRAC
activation was compared in mock and tsA201a cells
transfected with T84 derived ICln. VRAC activity was
initiated with a 90% hyposmotic gradient. Fig. 3A
shows current elicited by voltage ramps from 360
to +60 mV in tsA201a cells overexpressing T84 ICln
and mock transfectants. Reversal potential measure-
ments show the current is anion-selective under both
conditions (361 þ 2 and 352 þ 3 mV, respectively),
indicating that over-expression of ICln protein re-
sulted in a large net increase in anion current. If
overexpression resulted in a cation current, the rever-
sal potential would be expected to be more positive.
The greater negative reversal potential in tsA201a
cells overexpressing T84-derived ICln protein re£ects
the increased development of anion current in these
cells. Transfection with either GFP or CD8 served as
an internal control for the overexpression of a small
cytosolic protein (GFP) or membrane protein (CD8)
and did not alter the reversal potential or alter
VRAC properties.
T84-Derived ICln protein overexpression resulted
in a large increase in the rate of VRAC current de-
velopment (79 þ 24 pA/pF min31) as compared to
CD8- and mock transfectants (5 þ 3 and 8 þ 6 pA/
pF min31, respectively) (Fig. 3B). Similar results
6
Fig. 4. VRAC inactivation properties are independent of ICln
protein expression. (A) Time-dependent VRAC current decay in
mock and tsA201a cells transfected with T84 derived ICln. Volt-
age-dependent decay was determined using a conditioning pulse
protocol. A short test pulse (10 ms) +100 mV was applied fol-
lowing prepulses (500 ms) from 360 to +160 mV. (B) The mid-
point of current inactivation (R = (1+eV3V0:5=k)31) is the same
for mock (open squares: 121 þ 15 mV) and T84 ICln-transfected
(open triangles: 120 þ 16 mV) tsA201a cells. Inactivation of
VRAC in wild-type T84 (¢lled squares: 74 þ 2 mV) cells are in-
cluded as a reference. The slope factor in mock and T84 ICln
transfected tsA201a cells is similar (k = 32 þ 9 and 30 þ 3 mV,
respectively). The slope factor in wild-type T84 cells is 13 þ 1
mV. (C) Time constant of the exponential decay of currents
does not change with expression of T84 ICln cDNA in tsA201A
cells (open squares) and in mock-transfected tsA201a cells
(open triangles), but is signi¢cantly di¡erent from that of wild-
type T84 cells (¢lled squares). Each point represents an average
of recordings made from v 4 cells þ S.E.M.
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were obtained with overexpression of RPMI-derived
ICln cDNA (14 þ 8 pA/pF min31). VRAC current
did not develop in either control or ICln trans-
fectants under isosmotic conditions (data not
shown).
Overexpression of ICln protein did not alter VRAC
inactivation of the host cell line. Fig. 4 shows current
traces of voltage-dependent VRAC inactivation in
wild-type tsA201a and T84 ICln transfected cells in
response to a family of voltage pulses. The midpoint
of steady-state VRAC inactivation (R) is signi¢cantly
di¡erent in untreated, wild-type tsA201a, T84 and
RPMI 8226 cells (Vm = 121 þ 15, 74 þ 2.0 and
105 þ 3 mV, respectively) [14]. Overexpression of
T84 ICln protein in tsA201a cells does not change
the midpoint of inactivation (Vm = 120 þ 16 and
121 þ 15 mV, respectively), slope factor (k) (30 þ 3
and 32 þ 9 mV, respectively) or time course of inac-
tivation of the host cell line (Fig. 4). Similarly, there
was no change in midpoint of steady-state VRAC
inactivation (Vm = 121 þ 4 mV), the slope factor
(k = 32 þ 9 mV) or time course of inactivation in
tsA201a cells overexpressing RPMI ICln protein.
The similarity of the inactivation properties under
these conditions indicates the same VRAC is ex-
pressed, independent of the level of ICln protein
expression. Thus, the properties of VRAC in-
activation are independent of the level of ICln protein
expression and the di¡erences in Vm in the original
cell lines may be due to inherent properties of cell
lines.
3.4. ICln protein underexpression
Antisense oligonucleotides were used to examine
the e¡ect of underexpressing endogenous ICln protein
on VRAC properties. tsA201a cells were transfected
with antisense oligonucleotides (10 Wg) complemen-
tary to the published MDCK ICln sequence (see Sec-
tion 2). Control cells were transfected with sense oli-
gonucleotides (10 Wg) consisting of the ¢rst 24
nucleotides of MDCK ICln.
ICln protein underexpression in tsA201a cells was
con¢rmed through immunostaining. Fig. 5 shows
£uorescence images of cells transfected with antisense
and sense oligonucleotides. The mean pixel intensity
was greater in sense transfected tsA201a than in anti-
sense-treated cells (146 þ 18 and 118 þ 25, respec-
tively). Fluorescence intensity was decreased in cells
transfected with antisense oligonucleotides. The £uo-
rescence of cells transfected with sense oligonucleo-
tides was similar to that of mock transfected tsA201a
cells (159 þ 21).
3.5. ICln protein underexpression inhibits VRAC
activation
The e¡ect of ICln protein underexpression on
VRAC activation in tsA201a cells was compared in
sense and antisense transfectants. Fig. 6 shows cur-
rent traces elicited by voltage ramps from 360 to
+60 mV under hyposmotic conditions in antisense
and sense transfectants. The rate of VRAC current
Fig. 5. ICln protein underexpression using antisense oligonucleotides. (A) K-ICln followed by incubation with a £uorescent secondary
antibody demonstrates underexpression of endogenous ICln protein in tsA201a cells transfected with antisense oligonucleotides (10 Wg)
as compared to sense transfected cells. Scale bar indicates 10Wm. (B) Mean pixel intensity ( þ S.E.M.) per cell under each condition,
taken from v 25 cells per condition.
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development in antisense and sense transfected
tsA201a cells is also shown in Fig. 6. The rate of
current development in cells underexpressing endog-
enous ICln protein was signi¢cantly less than current
development in sense transfectants (0.1 þ 0.4 and
18 þ 5 pA/pF min31, respectively; nv 6) when chal-
lenged with a 90% osmotic gradient. Increasing the
osmotic gradient such that the osmolarity of the ex-
tracellular solution was 75% that of the intracellular
solution did not increase the rate of activation of the
current (0.06 þ 1.09 pA/pF min31 ; n = 7). These re-
sults indicate the rate of VRAC activation is depen-
dent on ICln protein expression levels. It was not
possible to compare VRAC inactivation under these
conditions because cells treated with antisense oligo-
nucleotides did not develop su⁄ciently high current
amplitude to develop inactivation.
4. Discussion
We determined the amino acid sequence of ICln
protein from three human cell lines, T84, RPMI
8226 and tsA201a. While the ICln amino acid se-
quence from human sources was nearly identical
(v 99% homology), the human ICln protein sequences
displayed less homology to rat and MDCK ICln
[1,2,15,16]. tsA201a cells expressing ICln cDNA iso-
lated from T84 cell line results in an increase in both
the rate of VRAC activation and current amplitude
during hypotonic swelling. Expression of ICln protein
derived from RPMI 8226 cells in tsA201a cells was
similar. Underexpression of endogenous ICln protein
using antisense oligonucleotides reduced the rate of
VRAC activation during cell swelling. Similar results
have been reported in NIH 3T3 ¢broblasts and bo-
vine nonpigmented epithelial cells [3,4]. We have
found expression of T84- or RPMI 8226-derived
ICln protein has no e¡ect on voltage-dependent
VRAC inactivation in tsA201a cells, indicating
VRAC inactivation is dependent on as yet indetermi-
nate characteristics of the host cell line rather than
on ICln protein expression levels or source.
ICln was ¢rst identi¢ed by expression cloning
cDNA from T84 cells in Xenopus oocytes [1]. It
was ¢rst thought that this cDNA encoded a channel
protein of novel structure. The cytosolic protein was
postulated to incorporate into the membrane in re-
sponse to osmotic stress. Subsequent work has not
supported this hypothesis. In addition, Xenopus oo-
cytes have been found to express an endogenous
swelling activated current in addition to an endoge-
nous form of ICln cDNA and that ICln induced cur-
rent is distinct from volume regulated anion current
[17]. Additional observations suggest that ICln expres-
sion may be a modulator of an unrelated chloride
channel protein, ClC-6 [18]. A recent report indicates
ICln protein can form a cation-selective channel when
reconstituted in planar lipid bilayers [6]. Although
there is no physiological evidence that ICln protein
Fig. 6. ICln protein underexpression inhibits VRAC activation. (A) Activation of VRAC in response to a 90% hyposmotic gradient in
tsA201a cells treated with sense and antisense oligonucleotides. Current was elicited in response to a voltage ramp from 360 to +60
mV over 500 ms, applied every 10 s. (B) The time course of VRAC current activation. The rate of VRAC activation was signi¢cantly
less in tsA201a cells transfected with antisense oligonucleotides (open symbols: 0.1 þ 0.4 pA/pF min31) as compared to sense trans-
fected cells (¢lled symbols: 18 þ 5 pA/pF min31). Each point represents average of recording made from v 6 cells þ S.E.M.
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forms either an anion- or cation-selective channel in
vivo, our results show no indication that ICln protein
expression results in an increase in cation current
when expressed in tsA201a cells. The speci¢c role
of ICln in volume regulatory processes remains un-
clear (for more discussion see [19]) but our work
and that of other indicates that the expression level
of this cytosolic protein in vivo does alter the activity
of a volume regulated anion current.
ICln protein association with actin and other cyto-
solic proteins (ICln binding proteins; IBPs) has been
documented [2,5]. IBP17 and IBP28, spliceosomal
proteins (Sm proteins) which are involved in remov-
ing introns from pre-mRNAs as is necessary for the
formation of a functional protein [20], were recently
shown to be associated with ICln protein. ICln protein
association with Sm proteins appears to inhibit pro-
tein expression by preventing intron splicing, suggest-
ing ICln protein may regulate transcription and trans-
lation processes of protein(s) expressed in response to
cell volume regulation.
In lymphocytes, disruption of F-actin in response
to a physiological hyposmotic challenge, such as that
used here, increases VRAC activation, while F-actin
stabilization decreases VRAC activation rate [14].
Cytoskeletal rearrangement in many cell types during
cell swelling is well-documented [21^25]. The associ-
ation of ICln protein with actin both in vitro and vivo
has been reported [5,26,27]. Together, these reports
suggest that ICln protein may interact with the actin
cytoskeleton to modulate VRAC activation. Re-
cently, a 72 kDa protein (IBP72) which consistently
co-localizes with ICln protein has been identi¢ed as a
possible mammalian homologue of yeast Skb1, a
protein that may in£uence cell morphology through
interaction with cytoskeletal proteins [28]. IBP72
binds to the carboxyl terminus of ICln, a region
that is highly conserved in di¡erent species and cell
types, suggesting this region may be functionally sig-
ni¢cant.
In summary, we show that the amino acid sequen-
ces of ICln from human sources are highly homolo-
gous (v 99%), while rat and MDCK sequences are
less homologous to human ICln. Our results support
the hypothesis that expression levels of ICln protein
modulate VRAC activation and thus may contribute
to cell volume regulation. These studies also show
that ICln protein is not likely to contribute to a di¡er-
ence in the voltage-dependent inactivation of VRAC
reported in many cell types.
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